GENEVA, Sept. 7 -- CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. filed a patent application (CN2026/080298) for “DOUBLE-STRANDED RIBONUCLEIC ACID THAT TARGETS COAGULATION FACTOR XI MRNA”. With publication no. WO/2026/179938, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....